Bulk Drug Substances (Active Pharmaceutical Ingredients) and Intermediates for the Pharmaceutical Industry 2022

Language:
Japanese
Product Code No:
C64121100
Issued In:
2023/01
#of Pages:
206
Publication Cycle:
  
Format:
PDF

Price

120,000 yen ($796.55)
(excluding consumption tax)
240,000 yen ($1,593.10)
(excluding consumption tax)
360,000 yen ($2,389.64)
(excluding consumption tax)
* Equivalent value in US$ (Today's rate : $1= 150.65 yen , 2024/02/27 Japan)
*Scope of Each License Type

Coverage: (Product/service)

Bulk Drug Substances (Active Pharmaceutical Ingredients) and Intermediates for Pharmaceuticals

Research Target:

Bulk Drug Substances (Active Pharmaceutical Ingredients) and Intermediates for Pharmaceuticals

Research Content:

I   Market Trend Analysis of Bulk Drug Substances (Active Pharmaceutical Ingredient) and Intermediates for Pharmaceuticals

1. Transition of Market Size of Bulk Drug Substances and Intermediates (FY2015 - FY2019)
2. Trends of Companies developing Bulk Drug Substances and Intermediates
3. Problems and Challenges for Companies developing Bulk Drug Substances and Intermediates
4. Market Outlook of Bulk Drug Substances and Intermediates
5. Estimated Market Size of Bulk Drug Substances and Intermediates (FY2020 - FY2024)

II   Analysis of Market Strategies Taken by Leading Developers of Bulk Drug Substances (Active Pharmaceutical Ingredient) and Intermediates for Pharmaceuticals

1. Business Outline
2. Recent Requests from Manufacturers that Developers Accept Orders from
3. Trend of R&D
4. Trend of Production and Quality Management
5. Sales Trends
6. Future Market Strategies
7. Promising Contractor Sectors and Business/Estimated Demands

III   Strategies of Contract Manufacturing of Bulk Drug Substances (Active Pharmaceutical Ingredient) and Intermediates at Pharmaceutical Companies

1. Thoughts and Business Positioning towards Outsourcing of Bulk Drug Substances and Intermediates
2. What to Outsource in Business of Bulk Drug Substances and Intermediates
3. Criteria to Select Outsourcing Companies in the Business of Bulk Drug Substances and Intermediates
4. Challenges and Problems in Outsourcing Business of Bulk Drug Substances and Intermediates
5. Thoughts and Directions in Outsourcing of Bulk Drug Substances and Intermediates
6. Bulk Drug Substances and Intermediates Expected to be Manufactured by Outsourcer
7. Criteria, Services, Facilities, and Knowledge Required in Outsourcing Companies for Manufacturing of Bulk Drug Substances and Intermediates
8. Potential of Outsourcing Business for Bulk Drug Substances and Intermediates for Pharmaceuticals

IV   Market Strategies Taken by Leading Companies of Bulk Drug Substances (Active Pharmaceutical Ingredient) and Intermediates for Pharmaceuticals

V   Profiles of Leading Companies of Bulk Drug Substances (Active Pharmaceutical Ingredient) and Intermediate for Pharmaceuticals

Price

written in Japanese
120,000 yen ($796.55)
(excluding consumption tax)
240,000 yen ($1,593.10)
(excluding consumption tax)
360,000 yen ($2,389.64)
(excluding consumption tax)
* Equivalent value in US$ (Today's rate : $1= 150.65 yen , 2024/02/27 Japan)
*Scope of Each License Type